Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

QuidelOrtho Corp

In Vitro & In Vivo Diagnostic Substances · San Diego, CA, United States

  1. PrincipalsBrian J. BlaserPresident and CEOJonathan Philip SiegristEVP of R&D & CTOJoseph M. BuskyChief Financial Officerand 10 more
  2. CompanyQuidelOrtho CorpSan Diego, CA, United States
  3. Phone line+1 (858) 552-1100General business
Request a quote

QuidelOrtho Corp is an SEC-registered Nasdaq-listed company (ticker QDEL) classified under SIC 2835: In Vitro & In Vivo Diagnostic Substances.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2835 — In Vitro & In Vivo Diagnostic Substances — SEC EDGAR company submissions

People 13

Chief executive

Brian J. BlaserPresident and CEO

Chair & board

Ann D RhoadsDirector (Board)
Joseph D Wilkins Jr.Director (Board)
Kenneth J WidderDirector (Board)
Mary Lake Ph D PolanDirector (Board)

Finance

Joseph M. BuskyChief Financial Officer

Operations

Philip D. McLellanChief Operations Officer

Technology & engineering

Jonathan Philip SiegristEVP of R&D & CTO

Legal

Michelle A HodgesChief Legal Officer
Nathaniel SisitskyChief Legal Officer
Everyone else on file (2)
Ronald Lee BowmanChief Human Resources Officer
Bryan Michael HansonEVP Global Port. Mgmt & Mkting

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Brian J. Blaser — President and CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Jonathan Philip Siegrist — EVP of R&D & CTO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Joseph M. Busky — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Michelle A Hodges — Chief Legal Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers